#United States #New York #Pomerantz LLP #Profound Medical #NASDAQ PROF

Introduction

In recent news, Pomerantz LLP has announced an investigation that aims to assist investors of Profound Medical Corp. (NASDAQ: PROF). This legal inquiry emerges in light of serious concerns regarding potential securities fraud and other unlawful business practices allegedly connected to the company. As Profound continues to reel from the regulatory scrutiny, investors are reminded of their rights and the means available to them for potential recovery of losses.

The Nature of the Investigation

The investigation by Pomerantz Law Firm has been prompted by a troubling disclosure from Profound Medical found in a recent filing with the U.S. Securities and Exchange Commission (SEC). On March 7, 2025, Profound revealed that it had identified a significant error which had overstated its revenue by $472,000 during the first quarter of 2024. This revelation indicates that prior quarterly reports for the first three quarters of 2024 are no longer reliable, leading the company to commit to filing restated interim financial statements as soon as possible.

Impact on Investors

Following the announcement of this financial discrepancy, Profound Medical’s stock price experienced a dramatic decline. The share price plummeted by $0.43, equating to a decrease of 5.9%, settling at $6.86 per share at the close of trading on the same day. This sharp decline has undoubtedly raised alarms among shareholders, prompting Pomerantz LLP to take action.

Pomerantz LLP: A Leader in Securities Litigation

Founded over 85 years ago by the late Abraham L. Pomerantz, the firm has positioned itself as one of the leading entities in corporate, securities, and antitrust class action litigation. The firm’s dedication to fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct has remained a constant in its operations. With numerous multimillion-dollar recoveries to their credit, Pomerantz remains a trusted name for investors seeking justice and reparations in the face of financial wrongdoing.

How to Get Involved

Investors who believe they may have been affected by this situation are encouraged to reach out to attorney Danielle Peyton at Pomerantz LLP for more information and guidance. Interested parties can contact her via email or phone, providing a direct line of communication for those impacted.

Contact Information:
Danielle Peyton
Pomerantz LLP
Email: [email protected]
Phone: 646-581-9980 ext. 7980

Conclusion

As this investigation progresses, it is crucial for investors to stay informed and proactive about their options regarding potential claims against Profound Medical Corp. and its management. The outcome of this investigation could have significant implications for all shareholders involved. Keeping abreast of developments will be essential in navigating this challenging situation effectively.